As of April 9, 2026, the CDC reports 1,714 confirmed measles cases in the United States year-to-date, with 1,704 among residents across 33 jurisdictions and 94% outbreak-associated from 17 new 2026 clusters plus lingering 2025 transmissions. Primarily affecting unvaccinated individuals amid declining MMR vaccination coverage (92.5% for kindergartners in 2024–2025, below the 95% herd immunity threshold), cases stem from imported infections by travelers from endemic regions, fueling small household-level outbreaks via highly contagious airborne spread (R0 of 12–18). Growth has slowed after an early-year surge, but surveillance lags could reveal more April incidents before the April 30 cutoff. Traders should watch the CDC's weekly Thursday update on April 17 for revised counts and containment progress.
Polymarket verilerine atıfta bulunan deneysel AI tarafından oluşturulmuş özet. Bu bir işlem tavsiyesi değildir ve bu piyasanın nasıl çözümlendiğinde hiçbir rolü yoktur. · GüncellendiABD'de 30 Nisan'a kadar kızamık vakaları?
ABD'de 30 Nisan'a kadar kızamık vakaları?
$190,168 Hac.
$190,168 Hac.
30 Nis 2026
1800
61%
1850
21%
1900
7%
1950
3%
2000
3%
2100
2%
2200
2%
$190,168 Hac.
$190,168 Hac.
30 Nis 2026
1800
$48,301 Hac.
61%
1850
$4,873 Hac.
21%
1900
$50,792 Hac.
7%
1950
$20,403 Hac.
3%
2000
$42,586 Hac.
3%
2100
$7,273 Hac.
2%
2200
$15,939 Hac.
2%
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by April 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of April 9, 2026, the CDC reports 1,714 confirmed measles cases in the United States year-to-date, with 1,704 among residents across 33 jurisdictions and 94% outbreak-associated from 17 new 2026 clusters plus lingering 2025 transmissions. Primarily affecting unvaccinated individuals amid declining MMR vaccination coverage (92.5% for kindergartners in 2024–2025, below the 95% herd immunity threshold), cases stem from imported infections by travelers from endemic regions, fueling small household-level outbreaks via highly contagious airborne spread (R0 of 12–18). Growth has slowed after an early-year surge, but surveillance lags could reveal more April incidents before the April 30 cutoff. Traders should watch the CDC's weekly Thursday update on April 17 for revised counts and containment progress.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by April 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Piyasa Açıldı: Apr 14, 2026, 9:30 AM ET
Hacim
$190,168Bitiş Tarihi
30 Nis 2026Piyasa Açıldı
Apr 14, 2026, 9:30 AM ETResolver
0x65070BE91...This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by April 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of April 9, 2026, the CDC reports 1,714 confirmed measles cases in the United States year-to-date, with 1,704 among residents across 33 jurisdictions and 94% outbreak-associated from 17 new 2026 clusters plus lingering 2025 transmissions. Primarily affecting unvaccinated individuals amid declining MMR vaccination coverage (92.5% for kindergartners in 2024–2025, below the 95% herd immunity threshold), cases stem from imported infections by travelers from endemic regions, fueling small household-level outbreaks via highly contagious airborne spread (R0 of 12–18). Growth has slowed after an early-year surge, but surveillance lags could reveal more April incidents before the April 30 cutoff. Traders should watch the CDC's weekly Thursday update on April 17 for revised counts and containment progress.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by April 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Hacim
$190,168Bitiş Tarihi
30 Nis 2026Piyasa Açıldı
Apr 14, 2026, 9:30 AM ETResolver
0x65070BE91...As of April 9, 2026, the CDC reports 1,714 confirmed measles cases in the United States year-to-date, with 1,704 among residents across 33 jurisdictions and 94% outbreak-associated from 17 new 2026 clusters plus lingering 2025 transmissions. Primarily affecting unvaccinated individuals amid declining MMR vaccination coverage (92.5% for kindergartners in 2024–2025, below the 95% herd immunity threshold), cases stem from imported infections by travelers from endemic regions, fueling small household-level outbreaks via highly contagious airborne spread (R0 of 12–18). Growth has slowed after an early-year surge, but surveillance lags could reveal more April incidents before the April 30 cutoff. Traders should watch the CDC's weekly Thursday update on April 17 for revised counts and containment progress.
Polymarket verilerine atıfta bulunan deneysel AI tarafından oluşturulmuş özet. Bu bir işlem tavsiyesi değildir ve bu piyasanın nasıl çözümlendiğinde hiçbir rolü yoktur. · Güncellendi
Harici bağlantılara dikkat edin.
Harici bağlantılara dikkat edin.
Sıkça Sorulan Sorular